Immunoreactivity and in-vitro effect on human sperm-egg binding of antibodies against peptides corresponding to bonnet monkey zona pellucida-3 glycoprotein

Afzalpurkar, A. ; Shibahara, H. ; Hasegawa, A. ; Koyama, K. ; Gupta, S. K. (1997) Immunoreactivity and in-vitro effect on human sperm-egg binding of antibodies against peptides corresponding to bonnet monkey zona pellucida-3 glycoprotein Human Reproduction, 12 (12). pp. 2664-2670. ISSN 0268-1161

Full text not available from this repository.

Official URL: http://humrep.oxfordjournals.org/content/12/12/266...

Related URL: http://dx.doi.org/10.1093/humrep/12.12.2664

Abstract

The following synthetic peptides were made as immunogens for development of a zona-based contraceptive vaccine: P1, KQPFWLLQGGASRAETSVQPVLVE [amino acids (aa) 23-45 with an additional K at the N-terminus]; P2, FSEEKLVFSLRLMEENC (aa 164-179 with an additional C at the C-terminus and T170 replaced by V); and P3, CSFSKSSNSWFPVEGPADICQCC (aa 300-322). The aa are numbered on the basis of bonnet monkey ZP3 precursor protein. Antibodies against an additional peptide P4, KGDCGTPSHSRRQPHVVSQWSRSA (aa 324-347), significantly inhibits human sperm-oocyte binding. In addition, antibodies against cocktail of peptide-diphtheria toxoid conjugates also significantly inhibit the binding of spermatozoa to zona pellucida in a hemizona assay. These results will further help in the design of an immunocontraceptive vaccine based upon synthetic peptides corresponding to ZP3.

Item Type:Article
Source:Copyright of this article belongs to Oxford University Press.
ID Code:72148
Deposited On:28 Nov 2011 06:11
Last Modified:28 Nov 2011 06:11

Repository Staff Only: item control page